Spatial OMICS and MetID

Tissue distribution studies of drug and drug metabolites is a key step in the drug development pipeline. Mass Spectrometry Imaging is an established and powerful MS technique that enables mapping of drugs and metabolites directly from tissue without target specific labels or reagents. To achieve this task, we integrated MetaSite and MassMetaSite capabilities within LipostarMSI to automatize the tasks of visualizing drug and metabolites distributions directly on-tissue and co-localizing within endogenous metabolites.

 

Leave a Reply